Vital Signs: Famsville’s Life Sciences and Healthcare Bi-Monthly Updates

Introduction

Happy 2025 from the Famsville Life Sciences and Healthcare Team!

As Nigeria’s healthcare and pharmaceutical industries evolve, regulatory developments and policy changes continue to shape the landscape. In this edition of Vital Signs, we provide a concise and insightful overview of the most critical updates, including legislative ad-vancements, executive approvals, and regulatory shifts.

From NAFDAC’s strategic roadmap for regulatory oversight to the Nigerian government’s increased funding for the healthcare sector, this issue highlights significant developments that impact stakeholders across the industry. Additionally, we cover the landmark executive order extending the retirement age for healthcare professionals and the mandatory inclusion of bioequivalence data in dossier submissions for generic drugs.

Whether you are a healthcare provider, legal professional, or pharmaceutical industry stakeholder, staying informed is crucial. We invite you to explore these updates and their implications, ensuring you remain well-equipped to navigate Nigeria’s dynamic healthcare landscape.

If you would like to discuss any of these developments or seek legal guidance, please do not hesitate to contact us. We look forward to engaging with you.

Welcome to the maiden edition of Vital Signs, Famsville’s magazine providing essential updates in Nigeria’s health and pharmaceutical sectors. From regulatory developments to executive approvals shaping the industry, we bring you key insights into the evolving legal landscape.

Get in Touch
DAYO ADU
Managing Partner, Famsville,
Dayo.adu@famsvillelaw.com